Vineet Laboratories Ltd

Stage 3 · Topping · week 1

As of 16 Oct 2026, Vineet Laboratories is in Stage 3 — topping, where an uptrend loses steam, in its first week (since 15 Oct 2026). It closed at ₹39.01, 18.5% below its 52-week high and above its 200-day average, which is falling. In Materials, 34.1% of stocks are in Stage 2.

Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and fine chemicals primarily in India. More about the company

₹39
+1.11% today
₹75 Cr · Micro cap
Market Neutral — FadingMaterials 34.1% in Stage 2-2.9 pts / 20dSpecialty Chemicals 44.9%-3.4 pts

Pro read

Pro

Our read

Topping — the uptrend is tiring

Setup score

—

Momentum

Accelerating ⇈

Edge

—

Is VINEETLAB early, or has it already run? Pro answers that for every NSE stock, after every close.

₹2,999 · 12 months₹1,999 · 6 months
Loading price chart…
vs 52W High
-18.5%
₹29 lo₹47.9 hi
18.5% below 52W high — weakening from peak
Stock is rolling over from its 52W high. Stage 3 distribution — new longs are high risk here.
Stage Maturity
Week 1
1w13w26w
Week 1 — early distribution
How long this stock has been in Stage 3 distribution. Longer tops often precede deeper Stage 4 declines.
vs 200 DMA
12.0%
200 DMA: ₹34.8 · sloping down
Stock is losing its 200 DMA. Once lost, it confirms Stage 4 risk. This is a major red flag for existing holders.
Rel Volume
4.28x
vs 50-day avg
Volume spikes on down days during Stage 3 signal distribution — institutions are exiting. A clear warning to avoid new longs.
Trend Health
↗ ⇈
Accelerating · MA20 +1.3% vs MA50 -0.7% / 10d
Two-layer momentum read: the glyph shows whether the 20-day MA is rising (↑/↗), flat (→), or rolling over (↓). The ⇈ flag fires when the 20-day MA is pulling away from the 50-day MA — short-term momentum building on top of the longer trend. Best when both glyphs agree.
1M
+8.7%
3M
+5.5%
6M
+18.9%
YTD
+7.8%
1Y
-4.2%
Sector
Materials
↓ Peaking
Stage 2%
34.1%
20d Δ
-2.9pp
1M return
-1.6%
3M return
-2.6%
Sector Stage-2 % · last 20 days
Sector has 153 Stage 2 leaders. See Materials Stage 2 →
Industry
Specialty Chemicals
↓ Peaking
Stage 2%
44.9%
20d Δ
-3.4pp
1M return
+0.5%
3M return
+9.2%
Industry Stage-2 % · last 20 days
Industry has 39 Stage 2 leaders. See Specialty Chemicals Stage 2 →
Stage Cycle Timeline2023-07-20 → 2026-10-16
S2 15w
S1 16w
S4 15w
S4 26w
2023-07-202026-10-16
S1S2S3S4Setup score (0–10, dashed line at 5)
S1 5w → S2 4w → S3 6w → S2 15w → S3 7w → S4 7w → S1 16w → S4 15w → S1 2w → S4 26w → S1 13w → S2 10w → S3 6w → S4 10w → S1 11w → S4 3w → S1 2w → S2 8w → S3 1w current
Total tracked: 168 weeks across 19 stage runs.
Scan Membership
Breakout Watch
Latest: 2026-08-18
2 appearances in last 60 days. First seen: 2025-10-24.
A stock that keeps qualifying week after week does so because its Stage 2 structure keeps holding — staying power in the scan says more about the trend than any single appearance.
Recent Stage Timeline
2026-10-16S3
Wk 1 · Vol 4.28x
2026-10-15S32→3
Wk 1 · Vol 0.81x
2026-10-14S2
Wk 8 · Vol 1.04x
2026-10-13S2
Wk 8 · Vol 0.97x
2026-10-12S2
Wk 8 · Vol 0.88x
2026-10-09S2
Wk 8 · Vol 0.55x
2026-10-08S2
Wk 8 · Vol 0.17x
2026-10-07S2
Wk 7 · Vol 1.16x
2026-10-06S2
Wk 7 · Vol 0.25x
2026-10-05S2
Wk 7 · Vol 0.97x
2026-10-01S2
Wk 7 · Vol 0.51x
2026-09-30S2
Wk 7 · Vol 1.19x
Sector Peers — Stage 2All →
OCCLLTD
wk 17 · -16.3% from hi
9.0
MUKANDLTD
wk 21 · -7.5% from hi
8.9
SUNFLAG
wk 3 · -9.3% from hi
8.8
CUBEXTUB
wk 2 · 0.0% from hi
8.7
NRL
wk 17 · 0.0% from hi
8.6
Moving averages & range
50 DMA
₹37.2
200 DMA
₹34.8
52W High
₹47.9
52W Low
₹29
5D Low
₹37.3
Resistance levels (recent highs)
20d High
₹39
60d High
₹39.8
120d High
₹39.8
250d High
₹47.9
Next resistance
+1.9%
to 60d High
Ask the Market AI about VINEETLABAsk →
About this companyMaterials· Specialty Chemicals

Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (API), intermediates, and fine chemicals primarily in India. The company offers intermediates of Lopinavir, Ritonavir, Efavirenz, Nadolol, Glimepiride, Celecoxib, Piroctone Olanine, and other API intermediates. It also provides fine chemicals and reagents, such as isopropyl-beta-d-thiogalactopyranoside, n-butyl lithium, 4-nitrophenyl phosphate disodium salt, 5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside, 5-acetyl thiophene-2-carboxilic acid, 4-chlorobutyryl chloride, n-butyl magnesium chloride, 3-furaldehyde, 3-bromofuran, n-butylnitrite, ethyldiazo acetate, phenylboronic acid, 6-aminouracil, and 1-methyl-imidazole-2-carboxaldehyde. The company was incorporated in 2016 and is based in Hyderabad, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-16. Past data patterns are not indicative of future results. This page is a data analytics tool only.